Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H13NO2S |
Molecular Weight | 223.291 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
S=C1NCCC(COC2=CC=CC=C2)O1
InChI
InChIKey=NIPRGEWHJUTVQK-UHFFFAOYSA-N
InChI=1S/C11H13NO2S/c15-11-12-7-6-10(14-11)8-13-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,12,15)
Molecular Formula | C11H13NO2S |
Molecular Weight | 223.291 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/277105
Sources: https://www.ncbi.nlm.nih.gov/pubmed/277105
Tifemoxone is a tetrahydrooxazine derivative patented by Delalande S.A. as an analgesic, spasmolytic, antidepressive agent. In preclinical studies, Tifemoxone caused thyreotoxicity, hairlessness and increased in water consumption and diuresis and in addition it had a strong hepatotoxic effect especially in the dog.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/277105
rat: 0, 85 and 230 mg/kg/d
dog: 0, 55 and 300 mg/kg/d.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:46:07 GMT 2023
by
admin
on
Fri Dec 15 15:46:07 GMT 2023
|
Record UNII |
09I93HJ3Y4
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Fri Dec 15 15:46:08 GMT 2023 , Edited by admin on Fri Dec 15 15:46:08 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB11037MIG
Created by
admin on Fri Dec 15 15:46:07 GMT 2023 , Edited by admin on Fri Dec 15 15:46:07 GMT 2023
|
PRIMARY | |||
|
3033964
Created by
admin on Fri Dec 15 15:46:08 GMT 2023 , Edited by admin on Fri Dec 15 15:46:08 GMT 2023
|
PRIMARY | |||
|
3747
Created by
admin on Fri Dec 15 15:46:07 GMT 2023 , Edited by admin on Fri Dec 15 15:46:07 GMT 2023
|
PRIMARY | |||
|
09I93HJ3Y4
Created by
admin on Fri Dec 15 15:46:07 GMT 2023 , Edited by admin on Fri Dec 15 15:46:07 GMT 2023
|
PRIMARY | |||
|
39754-64-8
Created by
admin on Fri Dec 15 15:46:07 GMT 2023 , Edited by admin on Fri Dec 15 15:46:07 GMT 2023
|
PRIMARY | |||
|
DTXSID50865969
Created by
admin on Fri Dec 15 15:46:07 GMT 2023 , Edited by admin on Fri Dec 15 15:46:07 GMT 2023
|
PRIMARY | |||
|
C75184
Created by
admin on Fri Dec 15 15:46:08 GMT 2023 , Edited by admin on Fri Dec 15 15:46:08 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105445
Created by
admin on Fri Dec 15 15:46:07 GMT 2023 , Edited by admin on Fri Dec 15 15:46:07 GMT 2023
|
PRIMARY | |||
|
C017760
Created by
admin on Fri Dec 15 15:46:07 GMT 2023 , Edited by admin on Fri Dec 15 15:46:07 GMT 2023
|
PRIMARY | |||
|
254-620-3
Created by
admin on Fri Dec 15 15:46:07 GMT 2023 , Edited by admin on Fri Dec 15 15:46:07 GMT 2023
|
PRIMARY | |||
|
100000082191
Created by
admin on Fri Dec 15 15:46:08 GMT 2023 , Edited by admin on Fri Dec 15 15:46:08 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |